These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 1020361

  • 1. [Effectivity of intermittent RMP/EMB treatment in patients with chronic pulmonary tuberculosis (author's transl)].
    Frenzel I, Neumeyer D.
    Z Erkr Atmungsorgane; 1976 Aug; 146(2):145-52. PubMed ID: 1020361
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of new and chronic tuberculous patients with ethambutol and Rifampicin (author's transl)].
    Pregowski W, Stanczuk A, Znaniecka H, Cesarz-Fronczyk M.
    Z Erkr Atmungsorgane; 1976 May; 145(2):220-6. PubMed ID: 983179
    [Abstract] [Full Text] [Related]

  • 3. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC, Heckscher T, Højgaard C, Larsen SO, Rasmussen KN, Vergmann B.
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [Abstract] [Full Text] [Related]

  • 4. [Studies of resumption of treatment with rifampin and ethambutol in patients with recurrent pulmonary tuberculosis].
    Jozefovics F, Barbu Z, Bálinth E, Ovári AM.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978 Mar; 27(3):177-84. PubMed ID: 212815
    [Abstract] [Full Text] [Related]

  • 5. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [Abstract] [Full Text] [Related]

  • 6. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 7. [Intermittent chemotherapy from the beginning or only after a period of daily administration? Quantitative bacteriological study at the initial phase of chemotherapy with INH + RMP + EMB in daily or intermittent administration].
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977 Nov; 26(4):193-205. PubMed ID: 204971
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC, Lee YC.
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [Abstract] [Full Text] [Related]

  • 10. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
    Anastasatu C, Bercea O, Barcan F, Stinghe R, Dinulică E, Marcovici M, Cristea M, Cărpinişan L, Gheorghiu M, Iancovici O, Ghinescu S.
    Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931
    [No Abstract] [Full Text] [Related]

  • 11. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of chronic pulmonary tuberculosis with rifampin and ethambutol by the continuous and intermittent methods].
    Kotowska M, Zelski S.
    Gruzlica; 1974 May; 42(5):417-9. PubMed ID: 4464230
    [No Abstract] [Full Text] [Related]

  • 13. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M, Chaulet P, Darbyshire JH, Nunn A, Fox W.
    Rev Mal Respir; 1986 May; 3(2):73-85. PubMed ID: 3726263
    [Abstract] [Full Text] [Related]

  • 14. [Relapse rate of pulmonary tuberculosis within two years following completion of twice weekly intermittent chemotherapy].
    Wada M, Okumura M, Hoshino H, Mitarai S, Ohmori M, Uchimura K, Yoshiyama T, Ogata H.
    Kekkaku; 2008 Apr; 83(4):353-8. PubMed ID: 18516898
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination.
    Zítková L, Janků I, Tousek J, Papezová E, Stastná J.
    Czech Med; 1983 Apr; 6(4):202-17. PubMed ID: 6420125
    [Abstract] [Full Text] [Related]

  • 16. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.